Subscribe to RSS



Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) Declares Upbeat Earnings Results – PGNX, GILD, GERN, ARNA, ZIOP

Shares of Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) jumped more than 29% on Friday that it had a loss and top Wall Street’s anticipations, and top the revenue anticipation. The revenue top is a optimistic sign to shareholders seeking high growth out of the firm.

The adjusted earnings a share surged to $-0.01 in the quarter against EPS of $-0.32 in the year-before quarter.

The revenue surged 303.64 percent to $8.88M from the year-earlier quarter.

Progenics Pharmaceuticals Inc. declared adjusted EPS loss of $0.01 a share. By that measure, the firm tops the mean analyst anticipates of $-0.31. It hammers the average revenue anticipates of $1.16M.

Moving readers toward the broader market, let’s consider percentage change in stocks prices of other stocks in the similar sector who contribute major role in the market that includes Gilead Sciences, Inc. (NASDAQ:GILD) lost -1.55%, Geron Corporation (NASDAQ:GERN) edged down -9.60%, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) which also decreased -0.99% and ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) closed up +3.31%.

Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) stock’s trade at beginning with a price of $3.60 and throughout the trading session climbed at a high of $4.94 other than when day-trade ended the stock finally advanced +28.99% to $4.36.

The stock is going forward its 52 week low with 209.22% and lagging behind from its 52 week high price with -61.55%. PGNX last month stock price volatility remained 8.68%.

PGNX stock institutional ownership remained 84.37% while insider ownership included 0.36%. In its share capital PGNX has 44.88 million outstanding shares among them 43.04 million shares have been floated in market exchange.

Company’s beta coefficient included 1.27. Beta factors measures the amount of market risk associated with market trade.


Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Entire Disclaimer Here

0 comments

Other articlesgo to homepage

On-top Session Stocks: BioFuel Energy Corp (Nasdaq:BIOF), LiveDeal Inc (Nasdaq:LIVE), Insteel Industries Inc (Nasdaq:IIIN), SGOCO Group Ltd (Nasdaq:SGOC), SanDisk Corp (Nasdaq:SNDK)

On-top Session Stocks: BioFuel Energy Corp (Nasdaq:BIOF), LiveDeal Inc (Nasdaq:LIVE), Insteel Industries Inc (Nasdaq:IIIN), SGOCO Group Ltd (Nasdaq:SGOC), SanDisk Corp (Nasdaq:SNDK)

Shares of BioFuel Energy Corp. (Nasdaq:BIOF) skyrocketed on Thursday’s market activity, currently trading for about $8.20, up $2.14 (or +35.30%), and 5,845,868 of its shares exchanged hands so far BioFuel Energy recently received a preliminary non-binding proposal, which suggested the company acquire acquire all of the equity interests in real-estate developer JBGL Capital and JBGL

Gaining Investiture Session Stocks: Zalicus Inc (Nasdaq:ZLCS), Zogenix Inc (Nasdaq:ZGNX), Lightbridge Corp (Nasdaq:LTBR), Apricus Biosciences Inc (Nasdaq:APRI), Alliqua Inc (Nasdaq:ALQA)

Gaining Investiture Session Stocks: Zalicus Inc (Nasdaq:ZLCS), Zogenix Inc (Nasdaq:ZGNX), Lightbridge Corp (Nasdaq:LTBR), Apricus Biosciences Inc (Nasdaq:APRI), Alliqua Inc (Nasdaq:ALQA)

Shares of Zalicus Inc. (Nasdaq:ZLCS) skyrocketed $0.32 (or +31.07%) to $1.35, following the announcement that Epirus Biopharmaceuticals, Inc., which has closed a $36 million Series B financing round, will merge with a wholly-owned subsidiary of Zalicus, to create a global biosimilar enterprise. 13,616,255 shares of Zalicus were traded on Wednesday, increased activity versus its average

Momentum Overcomers Session Stocks: SmartPros Ltd (Nasdaq:SPRO), Akebia Therapeutics Inc (Nasdaq:AKBA), WebMD Health Corp (Nasdaq:WBMD), bebe stores inc (Nasdaq:BEBE), Chindex International Inc (Nasdaq:CHDX)

Momentum Overcomers Session Stocks: SmartPros Ltd (Nasdaq:SPRO), Akebia Therapeutics Inc (Nasdaq:AKBA), WebMD Health Corp (Nasdaq:WBMD), bebe stores inc (Nasdaq:BEBE), Chindex International Inc (Nasdaq:CHDX)

The trading levels of SmartPros Ltd. (Nasdaq:SPRO) stock exploded on Monday’s market activity, closing at $2.99, up $0.77 (or +34.68%), and 334,315 of its shares exchanged hands during the day, a large increase on activity versus its average volume (3m) of 7,818 On intraday trading, SPRO stock reached a new 52 week high of $3.30

Bullish Prospective Session Stocks: JAKKS Pacific Inc (Nasdaq:JAKK), Rambus Inc (Nasdaq:RMBS), Rentech Inc (Nasdaq:RTK), Oramed Pharmaceuticals Inc (Nasdaq:ORMP), UBIC Inc (Nasdaq:UBIC)

Bullish Prospective Session Stocks: JAKKS Pacific Inc (Nasdaq:JAKK), Rambus Inc (Nasdaq:RMBS), Rentech Inc (Nasdaq:RTK), Oramed Pharmaceuticals Inc (Nasdaq:ORMP), UBIC Inc (Nasdaq:UBIC)

Shares of JAKKS Pacific, Inc. (Nasdaq:JAKK) soared $0.75 (or +9.96%) to $8.28, and 1,043,882 of its shares exchanged hands on Friday’s trading session. JAKKS Pacific, a leading designer and marketer of toys and consumer products, was upgraded from Market Perform to Outperform and its price target raised from $8.00 to $10.00 by brokerage firm BMO

Crown Equity Holdings Inc Surges on CRWE-PR network Achievement (OTCMKTS:CRWE)

Crown Equity Holdings Inc Surges on CRWE-PR network Achievement (OTCMKTS:CRWE)

With today’s stock market pullback in session, you can take a look at over-the-counter securities (OTC) – Crown Equity Holdings Inc ticker symbol (OTCMKTS:CRWE). Crown Equity Holdings Inc stock price has surged today as high as +13.64% Up 0.0009, currently at +6.06% Up 0.0004, just shy of 300K shares in play in the financial market

read more

Sign Up*

Receive Our Newsletter!

 



 

 

Contacts and information

Social networks

Most popular categories

© 2014 Crown Equity Holdings Inc. All rights reserved.